XML 70 R27.htm IDEA: XBRL DOCUMENT v2.4.1.9
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2014
Income Tax Disclosure [Abstract]  
Summary of Net Deferred Tax Asset

Our net deferred tax asset consisted of the following at December 31, 2014 and 2013:

 

     December 31,  
     2014      2013  

Deferred tax asset:

     

Net operating loss carryforwards

   $ 41,512,011       $ 36,837,171   

Deferred compensation

     1,082,211         881,025   

Depreciation and amortization

     1,161,055         886,149   

License impairment

     —           437,187   

Research and development credits

     3,761,004         194,132   

Accrued expenses

     47,356         97,326   

Impairment of investments

     730,830         —     

Other

     248,933         137,611   
  

 

 

    

 

 

 

Total deferred tax assets

     48,543,400         39,470,601   

Less: Valuation allowance

     (48,543,400 )      (39,470,601 )
  

 

 

    

 

 

 

Net deferred tax asset

   $ —         $ —     
  

 

 

    

 

 

 
Summary of Income Tax Provision (Benefit) from Income Taxes

The income tax provision (benefit) from income taxes consists of the following at December 31, 2014 and 2013:

 

     Years Ended December 31,  
      2014      2013  

Federal

     

Current

   $ —         $ —     

Deferred

     (6,333,053 )      (1,306,714 )

State

     

Current

     

Deferred

     (2,739,746 )      (224,232 )
  

 

 

    

 

 

 

Total

     (9,072,799 )      (1,530,946 )

Change in valuation allowance

     9,072,799         1,530,946   
  

 

 

    

 

 

 

Income tax provision (benefit)

   $ —         $ —     
  

 

 

    

 

 

 
Summary of Provision for Income Taxes Using Statutory Federal Tax Rate

The provision for income taxes using the statutory federal tax rate as compared to the Company’s effective tax rate is summarized as follows:

 

     December 31,  
      2014     2013  

Expected U.S. federal statutory rate

     (34.0 )%     (34.0 )%

State income taxes, net of federal benefit

     (14.6 )%     (5.8 )%

Deferred tax true-up

     —       18.7

R&D credit

     —       (1.4 )%

Other permanent differences

     —       0.3
  

 

 

   

 

 

 
     (48.6 )%     (22.2 )%

Change in valuation allowance

     48.6     22.2
  

 

 

   

 

 

 

Totals

     0     0